Clinical Trial for Experimental Centronuclear Myopathy Drug Given the Green Light
WikimediaImages / Pixabay

Clinical Trial for Experimental Centronuclear Myopathy Drug Given the Green Light

According to a story from BioSpace, the drug development company Dynacure recently released an announcement in which the company stated that its application for a Phase 1/2 clinical trial had…

Continue Reading Clinical Trial for Experimental Centronuclear Myopathy Drug Given the Green Light
Cognitive Bias in Idiopathic Pulmonary Fibrosis Management and Steps We Can Take to Avoid It
Source: Pixabay.com

Cognitive Bias in Idiopathic Pulmonary Fibrosis Management and Steps We Can Take to Avoid It

Cedric Rutland, a pulmonologist at Pacific Pulmonary Medical Group has shared his experience, research, and thoughts on cognitive bias in an effort to spread awareness for the issue, and hopefully,…

Continue Reading Cognitive Bias in Idiopathic Pulmonary Fibrosis Management and Steps We Can Take to Avoid It

MALARIA: Between One Million and Two Million Deaths Each Year Worldwide.  This Company is on Target to Treat Severe Malaria

An article in Globe Newswire quotes National Institute of Health statistics for malaria as being between 300 to 500 million cases worldwide resulting in 1.5 to 2.7 million deaths annually. People living…

Continue Reading MALARIA: Between One Million and Two Million Deaths Each Year Worldwide.  This Company is on Target to Treat Severe Malaria

First Ever Treatment for Transthyretin-Mediated Amyloidosis Cardiomyopathy Approved by FDA

Transthyretin-Mediated Amyloidosis Cardiomyopathy The FDA has just approved the very first treatment for hereditary or wild-type transthyretin-mediated amyloidosis cardiomyopathy (ATTR-CM).  ATTR-CM is a rare disease that occurs when amyloids, an…

Continue Reading First Ever Treatment for Transthyretin-Mediated Amyloidosis Cardiomyopathy Approved by FDA
After Neurofibromatosis Type 2 Prevented her From Getting Pregnant, her Twin Offered to Serve as a Surrogate
Free-Photos / Pixabay

After Neurofibromatosis Type 2 Prevented her From Getting Pregnant, her Twin Offered to Serve as a Surrogate

According to a story from KTVZ, Jill Noe and Whitney Bliesner have always shared a special bond. They are twins, now 34 years old. Despite their closeness, they do share…

Continue Reading After Neurofibromatosis Type 2 Prevented her From Getting Pregnant, her Twin Offered to Serve as a Surrogate
New Data on the Difference Between Plasma Cell Myeloma and Smoldering Myeloma Has Treatment Implications
ColiN00B / Pixabay

New Data on the Difference Between Plasma Cell Myeloma and Smoldering Myeloma Has Treatment Implications

A recent report that was published in the Swiss Medical Weekly outlines data gathered by a Swiss panel of experts on plasma cell myeloma. The report offers an update and…

Continue Reading New Data on the Difference Between Plasma Cell Myeloma and Smoldering Myeloma Has Treatment Implications
Could This Experimental Therapy be a Breakthrough for Genetic Amyotrophic Lateral Sclerosis?
NeuPaddy / Pixabay

Could This Experimental Therapy be a Breakthrough for Genetic Amyotrophic Lateral Sclerosis?

According to a story from fox43.com, an experimental therapy for the genetic form of amyotrophic lateral sclerosis (ALS) has been termed "game changing." A study that will soon be presented…

Continue Reading Could This Experimental Therapy be a Breakthrough for Genetic Amyotrophic Lateral Sclerosis?

Study Shows New Blood Test can Accurately Diagnose Chronic Fatigue Syndrome

Chronic Fatigue Syndrome Chronic fatigue syndrome (CFS) is a rare disease which causes, most notably, persistent fatigue that doesn't improve with rest. It is also sometimes referred to as myalgic…

Continue Reading Study Shows New Blood Test can Accurately Diagnose Chronic Fatigue Syndrome

Vascular Ehlers-Danlos Syndrome Patient Data Released Following Study

According to a story from globenewswire.com, the pharmaceutical company Acer Therapeutics recently announced the release of data from a long-term observational study of patients with vascular Ehlers-Danlos syndrome (vEDS). All…

Continue Reading Vascular Ehlers-Danlos Syndrome Patient Data Released Following Study

Drink One For Dane: Dutch Bros Coffee Hosts 13th Annual Amyotrophic Lateral Sclerosis Fundraiser This Friday, May 10th

Dutch Bros Coffee is hosting their 13th annual fundraiser for amyotrophic lateral sclerosis (ALS) this Friday, May 10th, 2019. It's called "Drink One for Dane" in honor of Dane Boersma,…

Continue Reading Drink One For Dane: Dutch Bros Coffee Hosts 13th Annual Amyotrophic Lateral Sclerosis Fundraiser This Friday, May 10th

Researchers Believe Lithium May be Key to Developing a Drug for Limb Girdle Muscular Dystrophy

The News Hub at Washington State University recently carried an article describing initial success by researchers towards developing a drug for a rare form of muscular dystrophy. Several thousand people…

Continue Reading Researchers Believe Lithium May be Key to Developing a Drug for Limb Girdle Muscular Dystrophy

Finding an Effective Personalized Therapy for Mastocytosis can be Frustrating, but it is Possible

What Exactly is Mast Cell Disease According to The Mastocytosis Society (TMS), there are three forms of mast cell disease. All involve the malfunction or over-development of mast cells in…

Continue Reading Finding an Effective Personalized Therapy for Mastocytosis can be Frustrating, but it is Possible
Despite Loss of Speaking Ability, This Amyotrophic Lateral Sclerosis Patient Testified to Congress in Support of Medicare for All
skeeze / Pixabay

Despite Loss of Speaking Ability, This Amyotrophic Lateral Sclerosis Patient Testified to Congress in Support of Medicare for All

According to a story from The Intercept, Ady Barkan's life is slowly slipping away as his amyotrophic lateral sclerosis continues to progress. Despite this, Ady has developed a reputation as…

Continue Reading Despite Loss of Speaking Ability, This Amyotrophic Lateral Sclerosis Patient Testified to Congress in Support of Medicare for All